[Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function]

Nihon Shokakibyo Gakkai Zasshi. 1987 Oct;84(10):2377-85.
[Article in Japanese]
No abstract available

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Hepatocellular / therapy*
  • Combined Modality Therapy
  • Embolization, Therapeutic
  • Female
  • Humans
  • Liver / drug effects
  • Liver / physiopathology*
  • Liver Function Tests
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / therapy*
  • Male
  • Middle Aged
  • Tegafur / administration & dosage
  • Tegafur / adverse effects
  • Tegafur / therapeutic use*
  • Uracil / administration & dosage
  • Uracil / adverse effects

Substances

  • Tegafur
  • Uracil

Supplementary concepts

  • 1-UFT protocol